Eupraxia Pharmaceuticals Inc. (EPRX)

NCM – Real Time Price. Currency in USD

6.51

-0.18 (-2.76%)

Market open: Aug 12, 2026, 10:14 AM EDT

6.70

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

11.08.2026

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single treatment of EP-104GI

10.08.2026

Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?

The consensus price target hints at a 145.4% upside potential for Eupraxia Pharmaceuticals Inc. (EPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Videos

No Data

There is no data to display

Press releases

11.08.2026

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single treatment of EP-104GI

Eupraxia Pharmaceuticals Inc. (EPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?

Videos

No Data

Press releases

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?

Videos

No Data

Press releases

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Search stocks

Eupraxia Pharmaceuticals Inc. (EPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?

Videos

No Data

Press releases

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?

Videos

No Data

Press releases

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results